Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AstraZeneca PLC - Offer for Cambridge Antibody Technology - Research and Markets offers a brief of 'AstraZeneca PLC' Conference Call.


DUBLIN, Ireland -- The AstraZeneca PLC (NYSE NYSE

See: New York Stock Exchange
:AZN AZN Asian ) Corporate Conference Call took place on 15-May-06 10:30am UKT UKT Quakertown, Pennsylvania (Airport Code)
UKT You Know That
.

AZN reported that the offer will be posted to the CAT shareholders shortly and the Co. expects to close around the end of June 2006. The addition of CAT to the Co.s organization will enable AZN to build a competitive biologicals capability that will work in tandem Adv. 1. in tandem - one behind the other; "ride tandem on a bicycle built for two"; "riding horses down the path in tandem"
tandem
 with its existing small molecule organization providing candidate drug to fuel a late-stage development pipeline and thereby a strong flow of new medicines to patients worldwide.

More information on this Conference Call can be obtained from Research and Markets at

http://www.researchandmarkets.com/transcripts/89109

This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUUK
Date:May 15, 2006
Words:131
Previous Article:Group of Thirty (G30) Reveals Final Global Clearing & Settlement Report at May 22nd JPMorgan Press Event.
Next Article:Former Corporate Investor Communications, Inc. Executives Form Alliance Advisors, LLC - a Shareholder Meeting Consultancy.
Topics:



Related Articles
Zeneca Agrochemicals and Cambridge Discovery Chemistry Announce Collaboration.
Pill Wars.
Dyax Announces Collaboration With AstraZeneca On Antibody Discovery and Optimization.
Market leaders. (Market Watch).
CAMBRIDGE ANTIBODY TECHNOLOGY/AMGEN RESTRUCTURE AGREEMENT.
Playing it big: Young is sticking with a portfolio of large companies to weather financial storms.
Research and Markets: AstraZeneca Now Has Ten Products With Global Sales of US$ 1 billion.
AstraZeneca Licenses Regeneron's VelocImmune(R) Technology for Discovering Human Monoclonal Antibodies.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles